Coho Biologics

Executive Summary

Coho Biologics is a contract testing laboratory headquartered in Seattle, Washington, providing analytical services to the pharmaceutical and biotech industries. Founded in 2014, the company specializes in rapid, compliant testing for proteins, RNA, and nanoparticle formulations, supporting clients from preclinical development through cGMP quality control. Its advanced immunoassays, particle sizing, and cell-based assays enable reliable characterization of biologics and complex drug products. As a private, pre-clinical stage company, Coho Biologics serves as a critical partner for drug developers seeking outsourced analytical expertise, particularly in the growing field of genetic medicines and lipid nanoparticles. The company's mission centers on empowering therapeutic advancement with high-quality data, and its Seattle location positions it within a vibrant biotech ecosystem. While not a drug developer itself, Coho Biologics' services are essential to the drug development pipeline, and its growth prospects depend on expanding its customer base and service offerings in response to increasing demand for specialized biologics testing.

Upcoming Catalysts (preview)

• Q3 2026Expansion of cGMP Testing Capacity70% success
• Q4 2026Strategic Partnership with Major Biotech or Pharma60% success
• Q2 2026Launch of Novel Analytical Platform for RNA Therapeutics50% success